survodutide vs semaglutide A phase 3 trial reported in Nature Medicine shows weekly subcutaneous injections of survodutide, a glucagon receptor/GLP-1R dual agonist, lowered liver fat content and body weight in adults with obesity and at-risk Differential effects of semaglutide, tirzepatide,

Oxidative stress and diseases associated with high-altitude exposure

A diet high in processed foods and added sugars can disrupt the delicate balance of the gut microbiome, leading to inflammation and oxidative stress

It is important to continue taking the medication as prescribed by your doctor, even if you do not notice immediate changes in your mood

Nearly 50% of your GLP-1 release is determined by genetics Its not working in isolation

GLP-1 medications require consistent adherence, may require lifestyle modifications, and come with a titration period during which side effects are common

Step 3: Eat Your Water Include hydrating foods in your meals